FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to application of spiperone as an agent stimulating regeneration of pulmonary endothelium in chronic obstructive pulmonary disease.
EFFECT: technical result is revealed new ability of spiperone to stimulate increase of endothelial progenitor cells in blood, to prevent destruction of alveolar tissue, to stimulate regeneration of alveolar endothelium and to reduce activity of inflammation.
1 cl, 1 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR STIMULATING REGENERATION OF THE PULMONARY ENDOTHELIUM IN THE EVENT OF A COMBINATION OF METABOLIC SYNDROME AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN WOMEN | 2020 |
|
RU2759231C1 |
| AGENT FOR PULMONARY ENDOTHELIAL REGENERATION STIMULATION AT METABOLIC SYNDROME COMBINED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2019 |
|
RU2712761C1 |
| METHOD FOR SIMULATING A COMBINED PATHOLOGY OF METABOLIC SYNDROME AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2019 |
|
RU2714679C1 |
| EARLY DIAGNOSTIC TECHNIQUE FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2010 |
|
RU2425369C1 |
| METHOD FOR PREDICTION OF INCIDENCE OF EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2023 |
|
RU2822081C1 |
| METHOD FOR EXPERIMENTAL SIMULATION OF INFLAMED PARANASAL SINUSES ACCOMPANYING CHRONIC TOBACCO SMOKING IN RATS | 2012 |
|
RU2522954C2 |
| METHOD FOR EARLY DIAGNOSIS OF INSULIN RESISTANCE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2019 |
|
RU2740587C1 |
| METHOD FOR EARLY PREDICTION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE OF DISEASE PROGRESSION | 2020 |
|
RU2740071C1 |
| METHOD OF TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2011 |
|
RU2458686C1 |
| COMPOSITION CONTAINING PURIFIED EXTRACT, EXTRACTED FROM Pseudolysimachion rotundum var.subintegrum CONTAINING GREAT AMOUNT OF ACTIVE COMPONENT,OR COMPOUNDS, EXTRACTED FROM IT, AS ACTIVE COMPONENT FOR PROPHYLAXIS OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND THEREOF | 2014 |
|
RU2594061C1 |
